# Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab

> **NCT01150643** · — · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 559 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **GENETIC:** gene expression analysis
- **GENETIC:** microarray analysis
- **GENETIC:** polymerase chain reaction
- **GENETIC:** polymorphism analysis
- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01150643
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12-06
- **Primary completion:** 2011-01-06
- **Final completion:** 2011-01-06
- **Target enrollment:** 559 (ACTUAL)
- **Last updated:** 2017-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01150643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01150643, "Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01150643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*